135 related articles for article (PubMed ID: 19760037)
1. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.
Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
Breast Cancer Res Treat; 2010 May; 121(1):185-94. PubMed ID: 19760037
[TBL] [Abstract][Full Text] [Related]
2. Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.
Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
Int J Cancer; 2009 Aug; 125(3):596-602. PubMed ID: 19358266
[TBL] [Abstract][Full Text] [Related]
3. Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases.
Bermejo JL; Kabisch M; Dünnebier T; Schnaidt S; Melchior F; Fischer HP; Harth V; Rabstein S; Pesch B; Brüning T; Justenhoven C; Brauch H; Baisch C; Ko YD; Hamann U
Int J Cancer; 2013 Jul; 133(2):362-72. PubMed ID: 23338788
[TBL] [Abstract][Full Text] [Related]
4. HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer.
Bialik P; Wysokinski D; Slomka M; Morawiec Z; Strapagiel D; Wozniak K
Exp Oncol; 2020 Jun; 42(2):130-134. PubMed ID: 32602284
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk.
Wozniak K; Krupa R; Synowiec E; Morawiec Z
Pathol Oncol Res; 2014 Jan; 20(1):67-72. PubMed ID: 23873416
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
8. SUMO pathway components as possible cancer biomarkers.
Mattoscio D; Chiocca S
Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
11. Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study.
Ahn K; Song JH; Kim DK; Park MH; Jo SA; Koh YH
Neurosci Lett; 2009 Nov; 465(3):272-5. PubMed ID: 19765634
[TBL] [Abstract][Full Text] [Related]
12. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of DNA double-strand breaks repair in breast cancer is decreased in carriers of the variant allele of the UBC9 gene c.73G>A polymorphism.
Synowiec E; Krupa R; Morawiec Z; Wasylecka M; Dziki L; Morawiec J; Blasiak J; Wozniak K
Mutat Res; 2010 Dec; 694(1-2):31-8. PubMed ID: 20863840
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide destabilizes Pias3 and regulates sumoylation.
Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C
PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106
[TBL] [Abstract][Full Text] [Related]
15. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
Lin JY; Ohshima T; Shimotohno K
FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
[TBL] [Abstract][Full Text] [Related]
16. Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy.
Han JY; Lee GK; Yoo SY; Yoon SJ; Cho EY; Kim HT; Lee JS
Pharmacogenomics J; 2010 Apr; 10(2):86-93. PubMed ID: 19859084
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.
Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron J; Weiderpass E
Breast Cancer Res; 2004; 6(4):R437-49. PubMed ID: 15217512
[TBL] [Abstract][Full Text] [Related]
18. Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.
Moschos SJ; Mo YY
J Mol Histol; 2006 Sep; 37(5-7):309-19. PubMed ID: 16758298
[TBL] [Abstract][Full Text] [Related]
19. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
20. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
Kim KY; Han W; Noh DY; Kang D; Kwack K
Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
